RGT anti-b bcln 150ML mncln ABO GRP BB
Ended Awarded Last action
- Contract number
- SPE2D326F099K
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,018
Award facts
- Contract value 100% obligated
- $1,018.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency (Medical Supply Chain) issued a delivery order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, on May 6, 2026, with a ceiling value of $1,018.08 for right-angle anti-B baseline 150 milliliter monoclonal ABO group blood bank reagent. Ultimate completion date is May 7, 2026.
Place of performance is Raritan, New Jersey. The order is priced as firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2D326F099K?
SPE2D326F099K was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on May 6, 2026.
How much is contract SPE2D326F099K worth?
The government has obligated $1,018 on SPE2D326F099K.
Is contract SPE2D326F099K an order under another contract?
Yes. SPE2D326F099K is a delivery order under SPE2D018D0005, an indefinite delivery contract.
Was contract SPE2D326F099K competed?
The extent of competition for SPE2D326F099K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award